Market Access
Find out everything you need to know about the latest pricing, reimbursement and market access strategies that will drive your business development.
4 Actions For Pharma to Remove Damaging Barriers with Customers
February 13 by Ernan RomanErnan Roman explores recent research showing that pharma and biotech companies make expensive mistakes by neglecting the power and necessity of customer experience strategies.
Pharma's missing ingredient in its outcomes focus: Value based pricing
February 06 by James WrightDelving into the common misconceptions surrounding value based pricing and value based payment in pharma.
Patients saved €7 million with generic medicines
January 16 by Chanice HenryThe market share of generics in Portugal reached a new record recently, according to provisional figures from Infarmed.
National price list enters into force
January 05 by Chanice HenryNew national price list for medical services went live on the first of January
What’s Next In the Fight Against the Opioid Crisis?
December 05 by David B. SudzusDavid B. Sudzus and Russell J. Chibe explore possible outcomes of the Blue Ribbon Commission Report and the Declaration of National Health Emergency regarding the U.S’s Opioid Crisis.
‘Brexit a major opportunity for UK pharma’
December 05 by Catalyst Corporate FinanceDespite concern expressed by the pharmaceutical industry, Catalyst Corporate Finance argues that the UK’s decision to leave the European Union in fact represents a major opportunity for the country’s...
Phytodrugs and the mysteries behind medicinal plants
November 21 by Joyce El HokayemHuman Genetics Scientist, Joyce El Hokayem examines the benefits phytomedicine could offer to today’s healthcare systems and the challenges researchers in this market face
How is artificial intelligence set to transform medicine?
October 31 by Pharma IQ NewsPharma IQ looks at the Potential of Artificial Intelligence in drug discovery.
India’s pharma industry strengthens
October 31 by Pharmaceuticals & Biotechnology EditorIndian pharmaceutical production expected grow 15 per cent by 2020 with domestic buying power sustaining revenues
Pharma: Your guide to breaking into social media
October 30 by Regina AuWhile social media is taking the consumer world by storm, the medical industry has been a bit shy to fully embrace these channels because of regulatory requirements.
Three survival tips for pharma firms facing the patent cliff
September 26 by Dr Steven BradshawPharma treads a fine line to the tipping point where there is insufficient time to recoup a drug’s costs, due to the number of years left that the patent can run.
European patients miss out due to drug pricing imbalance
September 19 by Chanice HenryAs the globe’s health systems groan under financial pressure, analysts have identified large differences in the amounts European patients pay for generics.